Stories from The University of Texas Health Science Center at Houston (UTHealth)
Physicians are studying whether vadadustat, an investigational therapy, could protect the lungs of COVID-19 patients by triggering the body’s protective response to low oxygen levels in a randomized Phase II clinical trial at UTHealth.
A new study shows a potential link between adolescent male suicide and intimate partner violence, as well as higher rates of suicide in rural white areas of Harris County, according to researchers from The University of Texas Health Science Center at Houston (UTHealth).
An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann - Texas Medical Center and Harris Health System’s Lyndon B. Johnson Hospital.
An early prognosis factor that could be a key to determining who will suffer greater effects from COVID-19, and help clinicians better prepare for these patients, may have been uncovered by researchers at The University of Texas Health Science Center at Houston (UTHealth). Results of the findings were published today in the International Journal of Laboratory Hematology.
